The agency is not recommending that women with otherwise normal symptoms after an implant should have their implants removed, according to Dr. William Maisel, chief scientist and deputy director for science in FDA's center for devices and radiological health.
American Society of Plastic Surgeons and the FDA will create a registry to monitor breast implants and examine reported cases. The agency requested that doctors report any ALCL cases they may have seen.
The FDA also says it will urge breast implant manufacturers in coming months to update their product labeling materials for patients and health care professionals to highlight the potential risk.
"We're excited to let the public know we're monitoring the situation," said Haeck. "What we don't want to cause is panic in the streets."
However, many experts said while registry and labeling are small steps forward, the FDA should independently review all potential harms associated with breast implants.
"There should be an honest effort to look into the harms breast implants could cause, and it should be irrespective of plastic surgeons who potentially stand to gain based on the outcome," said Harbut. "That's like the chickens asking the foxes to keep track of the eggs."